Mesothelioma Community Celebrates FDA Approval of Keytruda for Lung Cancer Treatment

Mesothelioma Community Celebrates FDA Approval of Keytruda for Lung Cancer Treatment
Mesothelioma Assistance Featured News Mesothelioma Community Commemorates FDA Approval of Keytruda for Lung Cancer Treatment The mesothelioma neighborhood is hailing the recent U.S. Food and Drug Administration’s approval of Keytruda for innovative (metastatic) non-small cell lung cancer (NSCLC). A recent U.S. clinical trial discovered Keytruda to be reliable in managing mesothelioma tumors in three-fourths of clients, leading scientists to state the results are “motivating.”

 


Please follow and like us:

Leave a Reply

Your email address will not be published. Required fields are marked *